XML 68 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Results of discontinued operations
9 Months Ended
Sep. 30, 2014
DiscontinuedOperationsAndDisposalGroupsAbstract  
Results of discontinued operations Disclosure

8.       Results of discontinued operations

Following the divestment of the Company's DERMAGRAFT business in January 2014, the Company recorded charges of $36.1 million and $64.0 million in the three and nine months to September 30, 2014 respectively, primarily relating to costs associated with the divestment including the loss on re-measuring to the fair value of the contingent consideration receivable from Organogenesis. These costs have been presented within discontinued operations in the consolidated income statement.

The operating results associated with the DERMAGRAFT business have been classified as discontinued operations in the consolidated statements of income for all periods presented. The components of discontinued operations which relate to the DERMAGRAFT business are as follows:

 3 months to 3 months to 9 months to 9 months to
 September 30,September 30,September 30,September 30,
 2014201320142013
 $’M$’M$’M$’M
Revenues:____________________________________________________________
Product revenues- 23.91.964.7
 ____________________________________________________________
Loss from discontinued operations before income taxes (37.9)(42.0)(81.8)(323.3)
Income taxes1.819.117.851.4
 ____________________________________________________________
Loss from discontinued operations, net of taxes(36.1)(22.9)(64.0)(271.9)
 ____________________________________________________________

The loss from discontinued operations in the three and nine months to September 30, 2014 includes a charge of $33.6 million as a result of re-measuring to fair value the contingent consideration receivable from Organogenesis.

The loss from discontinued operations before income taxes in the nine months to September 30, 2013 includes a charge of $191.8 million, being the proportion of the former Regenerative Medicine (“RM”) reporting unit goodwill impairment charge that related to the DERMAGRAFT business.